Widely used:Recently Viewed
Clear All
$6 Mln
--
3.64
--
0
-351.94 %
--
0 %
0.93
-944670
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Exicure (XCUR)
| -6.90 | 39.06 | 71.32 | -26.03 | -75.06 | -62.29 | -- |
|
BSE Sensex*
| 12.20 | -0.16 | 1.32 | 22.81 | 11.05 | 16.56 | 11.80 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|
|
Exicure (XCUR)
| -49.57 | -81.02 | -88.59 | -38.11 | -19.21 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
$5.87 Mln
$0.50 Mln
$0.00 Mln
$0.53 Mln
$7.32 Mln
Moderate
$1.44 - 10.00
2,172,320
NASDAQ: XCUR
Chicago, IL
https://www.exicuretx.com
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago,... Illinois. Read more
The total asset value of Exicure Inc (XCUR) stood at $ 14 Mln as on 30-Jun-24
The share price of Exicure Inc (XCUR) is $2.70 (NASDAQ) as of 04-Oct-2024 16:00 EDT. Exicure Inc (XCUR) has given a return of -75.06% in the last 3 years.
Exicure Inc (XCUR) has a market capitalisation of $ 6 Mln as on 04-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Exicure Inc (XCUR) is 3.64 times as on 04-Oct-2024, a 17% premium to its peers’ median range of 3.12 times.
Since, TTM earnings of Exicure Inc (XCUR) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Exicure Inc (XCUR) and enter the required number of quantities and click on buy to purchase the shares of Exicure Inc (XCUR).
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
The CEO & director of Mr. Paul Kang. is Exicure Inc (XCUR), and CFO & Sr. VP is Mr. Paul Kang.
There is no promoter pledging in Exicure Inc (XCUR).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,034
|
|
|
1,002
|
|
|
998
|
|
|
875
|
| Exicure Inc. (XCUR) | Ratios |
|---|---|
|
Return on equity(%)
|
-351.94
|
|
Operating margin(%)
|
-414.2
|
|
Net Margin(%)
|
-1634.4
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Exicure Inc (XCUR) was $0 Mln.
$-0.07
